Skip to main content
. 2018 Jan 18;13(1):e0191099. doi: 10.1371/journal.pone.0191099

Table 1. Control- and experimental-groups for transplantation.

Group Fraction (60μ1) Supplementation/scaffold *1
Contl non-fraction low-dose rhBMP2 *2 / β-TCP (20mg)
PB peripheral blood
PPP platelet-poor plasma
PRP platelet-rich plasma
BM bone marrow aspirate
BM-PPP bone marrow platelet-poor plasma
BMC bone marrow platelet-rich plasma

*1 bovine thrombin (10μl) and calcium chloride (10%) were added to each group before transplantation.

*2 low-dose rhBMP-2; 1.0μg for subcutaneous transplantation, and 0.5μg for calvarial transplantation.